{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-052962","form_type":"8-K","ticker":"NUTX","cik":"0001479681","company_name":"Nutex Health Inc.","filed_at":"2025-11-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.498057+00:00","generated_at":"2026-05-16T18:45:55.822593+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Nutex Health H1 2025 revenue $455.8M (+217.5% YoY), net income $3.5M, launches $25M buyback","bullets":["H1 2025 revenue $455.8M (+217.5% YoY); net income $3.5M vs net loss $0.7M in H1 2024.","Diluted EPS $0.55 (H1 2025) vs $(0.15); Adjusted EBITDA $144.4M vs $6.4M YoY.","Q2 2025 revenue $244.0M (+220.7% YoY); net loss $17.7M includes $78.7M non-cash stock-based comp.","Board authorized $25M stock repurchase program on Aug 14, 2025 to offset dilution.","Net cash from operations $78.2M H1; cash balance $96.7M at June 30, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-052962","json":"https://secwatch.observer/filing/0001628280-25-052962.json","markdown":"https://secwatch.observer/filing/0001628280-25-052962.md","text":"https://secwatch.observer/filing/0001628280-25-052962.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1479681/000162828025052962/0001628280-25-052962-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1479681/000162828025052962/nutx-20251118.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T18:45:55.822593+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}